CD22 and mantle cell lymphoma: These changes reflect the appearance of leukemic CD19+, CD20+, CD22+ B-cells with coexpression of CD5 and CD23 for CLL, CD11c, CD25 and CD103 for HCL, CD5 for MCL and CD10 for FL and are in good agreement with literature29, 30.